chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient came in for first dose and told pharmacist of her existing conditions. The pharmacist had the patient stay for 30 minutes after the vaccine.  about 20 minutes later the patient began to faint. Her mother, who was next to her, caught her in her chair and told us that this happens often when she is anxious. We immediately called 911. She was in and out for a few moments so we placed out a mat for her. When she came back to conciseness, she reported pain in her joints and acid reflux. We were able to give her fimotidine for the acid reflux.
Redness, warmth and itching to site. Prednisone 40 mg given to in office on 10/1/14. Script given for 30 mg for 1 week. Also advise to take BENADRYL 25 mg q 6 hours. Recheck in office in 48 hours. Erythema (10 cm x 10 cms)
Day after vaccine patient had chills and body aches. Patient also noticed arm swelling, redness, and warmth at the injection site that has persisted.
Moderna COVID - 19 VACCINE  Sorearm in left arm Chills Severe headaches Nausea and vomiting
Vaccination errantly given to someone under the age of 18.  Patient was 17yo and 11 month at the time.
No additional adverse effects reported; the patient was administered improperly stored PROQUAD; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. Concomitant medications included sterile diluent. The patient's pertinent medical history, concurrent conditions and drug allergies or reactions were not reported.     On 20-MAR-2019, the patient was vaccinated with an improperly stored dose of  measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), lot number R020678 and expiration date 15-JAN-2020, for prophylaxis (dosage schedule, route, and anatomical location were not reported).  The administered dose of the vaccine experienced a temperature excursion of 15 °F to 46 °F degrees Fahrenheit for 22 hours, as recorded by a data logger. No previous temperature excursion was reported. There was no adverse effect reported.
Roughly 2 weeks after taking the Flu vaccine at my work place, I became very sick with congestions,  chills and all the flu-like symptoms. could hardly speak out for days, because I lost my voice-- my management at work will testify to this. Initially, the cough was dry-- could not cough-it out, I took over the counter cough tablets and syrups, with pain relievers to decongest my self. currently, I still feel sick. This was not the first time I have experienced this.  in 2019, about 2 weeks after the flu-vaccine, I had shortness of breath, in 2021, I had serious congestions and coughs, I react to this vaccine, but it is mandatory at my work place, but it is also affecting my productivity.
heart attack; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team and legal division.  A female patient received bnt162b2 (BNT162B2), on 19Nov2021 as dose number unknown, signle (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "thyroid issue" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: MYOCARDIAL INFARCTION (death) with onset 21Nov2021, outcome "fatal", described as "heart attack". The patient date of death was 21Nov2021. Reported cause of death: "heart attack". It was not reported if an autopsy was performed. Additional information: Reporter lost mom (death) due to a covid vaccine she was given on 19Nov2021 and died 21Nov2021. Patient was mostly healthy woman with thyroid issue minimal high cholesterol etc. Patient suffered a heart attack caused by a pfizer vaccine she received states that on her death certificate.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: heart attack
The day after receiving the Pfizer Bivalent dose, I started to experience a fever, headaches, dizziness, chills and high heart rate. I kept going from hot to cold. My temperature was running over 100 degrees. I had to take TYLENOL to help me sleep. The following day, 11/12/2022, I still had spot headaches that would come and go. By mid-afternoon, I was still experiencing the headaches, but I was able to go for a walk. By 11/13/2022, the headaches were gone. I started to get hives around my hands/fingers/wrists, elbows and ankles on 11/18/2022. My foot was swollen where the hives were. More popped up around my calf. All in all, I noticed about 15-20 hives on my body. I took an antihistamine ALLEGRA (generic) for the hives and doxycycline for an antibiotic because one of them popped open. I also use a steroid cream on the hives.
12/31/2020  sore and swollen at site of injection 1/1/2021  sore at site and headache above right ear 1/2/2021 sore at site and headache above right ear 1/3/2021 headache and neck ache 1/4/2021 headache and stiff extremely painful neck 1/5/2021 headache,unable to move painful neck 1/6/2021 headache extremely painful neck,raised painful bump on neck called physician and set up telehealth call 1/7/2021 Same as yesterday but now several large fluid filled bumps on neck and shoulder.Telehealth call with Dr.  sent her pictures described pain prescribed prednisone 10mg 1/8/2021 Pain easing up;rash and bumps still present 1/9/2021 Pain much less, can move neck,bumps getting smaller but neck muscle is swollen
Here for injection site reaction to DTAP shot given Tues. He denies any fever, GI or respiratory sx. He was noted to have murmur on exam and is followed by cardiologist. He is with GM at encounter and few details are known about this.
Patient developed large mark around injection site that turned into a bruise (a little larger than a silver dollar). Bruise has faded significantly but faint outline is apparent 16 days after injection. No other pain in the arm and bruising was noticed by patient's husband, not the patient. Patient did develop flu like symptoms 1-2 days after that were completely resolved within 3 days of vaccination and sounded like a normal reaction to the vaccine.
This spontaneous report as received from a physician assistant via a company representative refers to a 32 year old female patient. The patient's medical history and concurrent conditions were not provided. On an unknown date, the patient was vaccinated with ZOSTAVAX 19400 PFU, (route, dose, lot # and expiration date were not provided). On an unknown date, after ZOSTAVAX administration, the patient experienced severe arm swelling at the injection site. The patient was evaluated at an unspecified emergency room on an unspecified date. At the reporting time, the outcome of the event was unknown. The causality was not provided. Additional information has been requested.
No period for 5+ months. Ultrasound at doctor on September 10 shows PCOS.  Always regular period previously to first vaccine. Had slight period on 8/30/21 for 3 days then as of 10/24/2021 no period since.
Patient reported adverse reaction from immunization (9/29/19) to the pharmacy on 10/1/19. She detailed having hives, labored breathing (chest tightness), congestion, drainage on 9/30/19. She also reported having a migraine/headache immediate after the administration of the immunization. Patient has been nursing her symptoms and monitoring  her progress.
Patient is a 91 y.o. male patient of a DO with history of atrial flutter, BPH, HTN, melanoma, NSVT, TIA who presented to a local Hospital with 2 to 3 days of productive cough sinus congestion and anorexia. Family felt he wasn't taking his medication and not eating.    Covid-19 Virus Infection Date of onset of symptoms: 5/17/23 Symptoms present on admission: cough, congestion Date of covid positive test: 5/19/23 Vaccination status: vaccinated Imaging: CXR no infiltrates  Oxygen requirements on admission: none Current oxygen requirements: 3 L NC, weaned down to RA at discharge Medical therapy:  ? With increase in O2 requirement, started on dexamethasone ? Scheduled Mucinex for congestio ? Scheduled Mucinex for congestion  ? 500ml fluid bolus as mildly dehydrated on admission Anticipated special isolation end date: 5/28/23 Improved over the course of hospital stay and DC home on 5 days of dexamethasone. Acute respiratory failure Did not require any O2 on admission.  But later on O2 requirement increased to 3 L NC Was able to wean down to RA prior to discharge.  Checked O2 requirement prior to discharge.  Did not qualify for oxygen   Atrial flutter Follows Dr. of Cardiology Continue home Eliquis   TIA Hyperlipidemia Continue home statin and Eliquis
11 days after Moderna booster shot: Began experiencing spontaneous urticaria and dermatographia on neck, scalp, legs, arms, and hips/groin area. Itchy, red hives and ghost lines would appear suddenly for about 30 minutes before fading again. Elastic waistbands, tight clothing made reaction worse. Treated with Benadryl for 3 days before discontinuing and instead starting a daily 24hr allergy medication (fexofenadine 180mg). Urticaria/dermatographia reappear when medication wears off. Either this reaction or this new medication has been causing chest and throat pain, mainly a feeling of tightness in the throat. No shortness of breath. Added in cimetidine 200mg twice daily, beginning 9 days after reaction, for possible acid reflux. Reaction is currently manageable with 180mg daily fexofenadine and two daily 200mg cimetidine.
woke up in the middle of the night with nausea, headache, fever, loose stool, heart palpitations and utterly exhausted. Lots of nigfht time sweating and enough so bed and pillow were wet in the morning. Continued until today where I am feeling better but still not feeling great.
Has developed urticaria overnight. The only medication he had while in the hosp was an influenza immunization so have to assume allergy to it. He has large urticaria of both antecubetal spaces axillae groin, buttocks. His eyelids are puffy. He is itching. Otherwise he is doing ok.
32 year endurance athlete with never any issues.  Within 2 weeks of second vaccine now have chest pain, shortness of breath, and high heart rate.  Been to listed family doctor.  Got EKG, Halter monitor test, and Echocardiogram.  Now told I have mild to mid leaky heart valve.
Two months after receiving the third COVID shot (Pfizer), I experienced an episode of severe vaginal bleeding that lasted more than two months.
Rapid heart rate; Feeling shaky and anxious; Feeling shaky and anxious; This is a spontaneous report from a contactable nurse (patient). A 24-year-old female patient received the first dose of BNT162B2  (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number:EL0142, expiration date unknown) , via an unspecified route of administration in the left arm on 14Jan2021 at 09:15 AM at a single dose for COVID-19 immunization.  Medical history included COVID-19 on unknown date prior to vaccination, patient had no known allergies. Patient is not pregnant. Concomitant medications included over the counter (OTC) vitamins. The patient had not received other vaccines in four weeks. On 14Jan2021, the  patient experienced rapid heart rate noted in the 150s approximately five minutes after receiving first dose lasting only a few minutes and was feeling shaky and anxious. There was no treatment received for the adverse events. The patient was not tested for COVID post vaccination. The outcome of the event rapid heart rate was recovered on 14Jan2021 while the rest of events was unknown.
09/21/22 presents to local Center Triage for "contractions" "40w2d". PMHx of "no pertinent past medical history"
Sever back and back pain since getting vaccine. Fever on and off since receiving vaccine highest being 101. Tylenol and ibuprofen taken to lower fever and help with pain. Fever and chills and pain still continuing
Information has been received from a certificated medical assistant referring to a patient of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On 03-JUL-2015 the patient was vaccinated with an improperly stored dose of GARDASIL (lot # K006117, expiration date 14-JAN-2017, dose and route were not reported). Concomitant drug was not reported. This is one of several reports from the same reporter. Additional information has been requested.
Injection site soreness; Body aches; Chills; Tiredness; Mental Fog; This is a spontaneous report from a contactable consumer (patient). A 33-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number and Expiry date: unknown) administered in Arm Right on 24Feb2021 at 12:00 (age at the time of vaccination was 33 -year-old), as dose 2, single for COVID-19 immunization. The patient's medical history included Covid-19. The patient's concomitant medications were not reported. The patient did not take any other vaccine in four weeks prior COVID -19 vaccine. The patient was diagnosed with COVID prior vaccination and not tested with COVID post vaccination. The patient had no known allergies. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: unknown, via an unspecified route of administration, administered in the right arm on 03Feb2021 at 12:00 (age at the time of vaccination was 33-year-old), as dose 1, single for COVID-19 immunization. On 25Feb2021, after the second dose of vaccine the patient experienced injection site soreness, body aches, chills, tiredness and mental fog. The patient underwent lab tests and procedures which included PCR covid test was positive prior vaccination on an unspecified date. Treatment received no for all the events. The outcome of the events was recovering.  No follow-up attempts were possible. Information about lot/batch number could not be obtained.
but the patient did not return for the third dose ofGARDASIL as scheduled on an unspecified date.; No additional AE information provided; the patient did not return for the third dose of GARDASIL as scheduled on an unspecified date. Nurse reported the patient was now 29 years old and was in the physician office on 2/3/2020 to complete the HPV vaccination series with a dose of GARDAS; This spontaneous report has been received from a nurse, referring to a 20 years old female patient. The patient's historical condition, concurrent condition and concomitant therapy were not reported.  On 03-FEB-2010, the patient was administered with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (lot# reported as 0969Y, but upon internal validation as 663573/0969Y; expiration date: 09-OCT-2011, dose, strength, frequency and route not reported) for prophylaxis. On 14-APR-2010,  the patient was administered with the second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (lot# reported as 0969Y, but upon internal validation as 663573/0969Y; expiration date: 09-OCT-2011, dose, strength, frequency and route not reported) for prophylaxis. But the patient did not return for the third dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) as scheduled on an unspecified date (inappropriate schedule of vaccine administered). On 03-FEB-2020, the patient was in the physician to complete the HPV vaccination series with a dosage form of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, frequency, route, lot# and expiration date were not reported) for prophylaxis (interchange of vaccine products). No additional event provided.
29APR93 PM began to c/o pain & achiness on rt side of neck like slept on it wrong; 30APR93 more persistant about same c/o was uses heating pad, 1MAy93 AM rt jaw area, especially just under jaw, very firm, swollen & painful; no fever present
Presented to the ED on 8/11/2021 for painful back mass. She did not have any covid symptoms but tested positive. No prior positive test results for COVID-19 documented.
This spontaneous report was received from a physician concerning a 3 months old male patient. The patient's medical history included reflux, and his concurrent conditions were not reported. He had no drug reactions or allergies. His concomitant medications included ranitidine hydrochloride (ZANTAC) and omeprazole. On 06-DEC-2018, the patient was vaccinated with the first dose of ROTATEQ orally (lot # R021069, expiration date: 18-APR-2020) for prevention of rotavirus. On 22-JAN-2019,  during a routine visit to the physician, it was noticed that the patient's weight percentile was trending downward (weight decreased). The physician determined the patient was experiencing difficulty with feeding and as treatment, the physician directed patient's mother to increase the amount of calories the patient was receiving via breastfeeding and formula feeding. Then, on 06-FEB-2019, the patient received the second dose of ROTATEQ orally (lot # R021069, expiration date: 18-APR-2020)  also for prevention of rotavirus. Due to the patient's difficulty with feeding, patient had a swallow study which was performed on an unknown date in 2019, which determined the patient was experiencing "silent aspiration" (also reported as it was unknown whether this meant the patient may have aspirated dose of ROTATEQ). On 14-MAR-2019, as it was scheduled, the patient was admitted in a hospital for placement of a nasogastric tube which was performed on an unspecified date in March 2019 during hospitalization. On 20-MAR-2019, the patient was discharged from the hospital. Since placement of the nasogastric tube, the patient was not permitted to receive anything by mouth and had not received his third dose of ROTATEQ. It was reported that patient was recently switched from ranitidine hydrochloride (ZANTAC) to omeprazole. At the reporting time, the patient had not recovered from the silent aspiration and weight decreased. The causal relationship between the events and ROTATEQ was not reported.  Upon internal review, silent aspiration was determined to be medically significant.
Patient states that approximately 20-30 minutes after injection of MMR she noticed a rash around injection site. She described it as "spider bites", said it was very itchy.  States it lasted 1 week but never sought medical attention.  States she did have a mild rash on right arm as well but not as much as on the left arm around MMR site.  Did not take any medication such as BENADRYL.
After 4-5 days of the immunization, both of her wrists and fingers started aching with nightly inflammation. She feels it may be getting better but she saw Nurse Practitioner on 12/5/17. Upon consulting Nurse Practitioner's office, I was informed that she could not rule out immunizations as causes for her symptoms but may not be related since both of her hands/wrists are in pain. Patient is taking 2 ibuprofen 200mg 3-4 times daily for her pain. Inflammation worse during night and subsides in the AM.
7 hrs later I went down to the ground. I tried getting up but i couldn't get up. My body was paraylzed. 12 hrs later my friend got me out of the chair. I couldn't walk my legs were in pain. I wasn't able to move. 4 days i had no bowel movements.
Headache, muscle and joint aches, chills and sweats, feeling tired, and nausea. Started about 9 and half hours after vaccinated, ended about 36 hours after vaccinated. Did not take day off from work, have a physical  job.
Redness at injection site; chills, body aches, fever & temperature 101.1, until 9am on 4/4/21.  Temperature and aches at 99.8 degrees all day.  By Monday, 4/5, fever had lowered to 98.7 but still feeling slow/lethargic most of Monday thru Tuesday, 4/6/21.  Left arm was sore with slight swelling and redness from 4/4 - 4/7/21.
Arthritis in joints?shoulders/ hands / wrist One week later ?still quite  painful in knuckles, fingers, and wrist.  Swelling in right hand.  No previous symptoms of arthritis prior to injection of Moderna Bivalent.
Information has been received from a physician concerning a female (age not reported) with established papilloma viral infection and a colposcopy was performed who on an unspecified date was vaccinated with HPV (lot# not reported). Subsequently, the patient experienced an outbreak of genital warts. Medical attention was sought. The outcome of the genital warts was not reported. Additional information has been requested.
Within days of receiving Influenza vaccine, I experienced tingling in my legs and feet and occasionally in my face. Patient still has tingling and some numbness in her right great toe and right 2nd digit. Also have tingling in her legs, especially in the am. Patient also reports that this has occurred each year for the past 3 years after receiving the vaccine. This is the first time she reported the symptoms.
Information has been received from a legal firm regarding a case in litigation concerning a male who on 4/19/99 and 9/16/99 was vaccinated with hep B vaccine recombinant (not batch reported). Concomitant therapy included Acel-Imune and HibTITER given on 5/19/99, 7/15/99, 9/16/99 and 7/11/00. It is alleged that the pt developed mercury poisoning by the cumulative doses of mercury in thimerosal and now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning. The pt reportedly was exposed to thimerosal-containing vaccinations administered from approximately April 1999 to July 2000. Upon internal review, mercury poisoning and toxic neurological effects of mercury poisoning were considered other important medical events (OMIC). No further info is available.
Initial case received from a physician on 08 September 2011. It pertains to 1 of a cluster of 2 patients who experienced similar events following FLUZONE vaccination; information for the other patient is found in case number 2011-08442. A female patient was diagnosed with the flu after receiving FLUZONE (lot not reported) on 02 September 2011. The patient was a nurse in a pediatric health care facility. The patient had no flu-like symptoms, however tested positive for Type A flu (no subtesting done). Outcome was not reported. Documents held by sender: None.